State Of Tennessee, Treasury Department Catalyst Pharmaceuticals, Inc. Transaction History
State Of Tennessee, Treasury Department
- $25.5 Billion
- Q1 2025
A detailed history of State Of Tennessee, Treasury Department transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 49,799 shares of CPRX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,799
Previous 50,587
1.56%
Holding current value
$1.04 Million
Previous $1.06 Million
14.41%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CPRX
# of Institutions
383Shares Held
99.5MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$116 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$71.8 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$65.8 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.16B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...